GRIN2D and neoplasm: The resulting surge in glycolytic activity, prompted by BHLHE40 and GRIN2D, not only sustains tumor cell survival and proliferation but also correlates with poor histological differentiation and more aggressive tumor phenotypes, thus contributing to the overall malignancy of GC.